News
Cosmos Holdings, Inc. Announces Q2 2020 Financial and Operating Results
CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the three months ended June 30, 2020: -For the three months ended June 30, 2020, revenues increased by 50.6% to $12.8 million from $8.51 million in the same period in 2019. -Quarterly gross profits increased to $2.3 million from ...
Cosmos Holdings, Inc. Announces Year End 2019 & Q1 2020 Financial and Operating Results
CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year ended December 31, 2019 and the quarter ended March 31, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the year ended December 31, 2019: -Operating revenues increased in 2019 by 7.0% to $39.7 Million from $37.1 Million in 2018. -Gross profits improved by 52% year over year. For the twelve months ...
COSMOS HOLDINGS, INC. SIGNS FOR EXCLUSIVE REPRESENTATION AGREEMENT OF COVID-19 DIAGNOSTIC DETECTION KIT FOR GERMANY, ENGLAND, GREECE & CYPRUS
CHICAGO, April 08, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has signed a definitive agreement with SunMed Biosciences Limited to be the exclusive representative and distribution agent of a rapid Diagnostic Detection Kit (DDK) into four EU countries: Germany, England, Greece and Cyprus. Specifically, this product is used for qualitative detection of the presence of IgM and/or IgG antibody to SARS-CoV-2, virus that causes COVID-19, in human serum, ...
Cosmos Holdings Engages Exchange Listing To Assist with its NASDAQ-Listing
CHICAGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings Inc. (OTCQB: COSM) (the “Company”) today announced it has engaged Exchange Listing LLC to assist with the planning and implementation of an up-listing of its common stock to the NASDAQ Capital Markets. “We plan to list our securities on NASDAQ Capital Markets as a next stage in our corporate growth and development,” said Greg Siokas, Chief Executive Officer of Cosmos Holdings. “We believe such a listing will provide a broader trading platform ...
Cosmos Holdings, Inc. Completes $550,000 Debt-to-Equity Conversion at $7.50 Per Share
CHICAGO, June 25, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“Cosmos” or the “Company”) (OTCQB: COSM), an international pharmaceutical company, announced today it agreed to issue 73,334 shares of common stock to Grigorios Siokas, the Company’s CEO, in exchange for the repayment of $550,000 of loans due to Mr. Siokas. The effective conversion rate is $7.50 per share, 95.8% higher than the $3.83 closing share price of Cosmos on June 24, 2019. Following the conversion of the loans, Cosmos will ...
Photo
David E. Gutierrez
Head of PR, IR
and Corporate Development

Join our mailing list to stay up to date.

Cosmos-logo